Advancing therapies for unmet medical needs
elketherapeutics is a Brooklyn-based biotech company focused on translating promising science into innovative therapeutic programs. We are building a research-driven pipeline designed to create meaningful possibilities for patients, healthcare professionals, and partners.
Our approach to therapeutic innovation
From scientific discovery through development strategy, elketherapeutics brings focused expertise to the work of advancing potential new medicines. Explore the foundations of our company, research, and pipeline.
Scientific discovery
Our work begins with rigorous scientific inquiry. We evaluate emerging biology, therapeutic targets, and innovative approaches that may address areas of significant unmet need.
Translational research
We connect early scientific insight with a practical development perspective, generating the evidence needed to inform thoughtful decisions and move programs forward responsibly.
Therapeutic pipeline
Our pipeline reflects a disciplined commitment to advancing differentiated therapeutic candidates with the potential to improve the treatment landscape for patients.
Collaborative development
Progress in biotechnology depends on strong collaboration. We welcome conversations with researchers, healthcare stakeholders, and strategic partners who share our commitment to advancing science.
“At elketherapeutics, our purpose is clear: pursue science with rigor, develop with intention, and keep the potential impact on patients at the center of every decision.”
— The elketherapeutics team
Partner in the pursuit of better therapies
Learn more about elketherapeutics, our scientific focus, and the programs shaping our development pipeline.
Questions about elketherapeutics?
We welcome inquiries from prospective collaborators, scientific partners, and others interested in our biotech research and development efforts.
Connect with elketherapeutics
Brooklyn, New York
United States
Office hours
Monday–Friday
9:00 a.m.–5:00 p.m. ET
Phone
[[phonenumber]]